Value proposition

Discovering the relationships at the heart of biology
to cure disease.

We are an end-to-end biotech developing transformational medicines, with technology at our core.

Our ambition is to understand human biology in an unprecedented way; discovering therapies that will treat some of life's most devastating diseases. We leverage single-cell and multi-omics measurements directly from patient tissue, functional assays and machine learning to drive disease understanding — from cause to cure.

Medicines born from high-resolution biology, machine learning and clinical insights.

Our Lab-in-the-Loop seamlessly integrates single-cell analysis, genomics and machine learning. We have developed powerful technologies which we apply to select druggable targets and develop transformational medicines.

machine learning and single cell